FUMAGALLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 5.225
EU - Europa 2.750
AS - Asia 1.780
SA - Sud America 92
AF - Africa 25
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.900
Nazione #
US - Stati Uniti d'America 5.144
SG - Singapore 710
RU - Federazione Russa 543
CN - Cina 538
IT - Italia 510
DE - Germania 449
SE - Svezia 435
IE - Irlanda 269
HK - Hong Kong 191
GB - Regno Unito 167
VN - Vietnam 104
BR - Brasile 83
UA - Ucraina 79
CA - Canada 74
FR - Francia 69
DK - Danimarca 66
ID - Indonesia 54
IN - India 51
TR - Turchia 42
FI - Finlandia 34
AT - Austria 32
JP - Giappone 25
KR - Corea 23
NL - Olanda 22
AU - Australia 21
BE - Belgio 20
ES - Italia 11
ZA - Sudafrica 11
EG - Egitto 9
IR - Iran 9
PL - Polonia 8
TW - Taiwan 8
CH - Svizzera 6
HR - Croazia 6
RO - Romania 6
CZ - Repubblica Ceca 5
EU - Europa 5
BG - Bulgaria 4
PT - Portogallo 4
SA - Arabia Saudita 4
KZ - Kazakistan 3
PH - Filippine 3
PK - Pakistan 3
RS - Serbia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
EC - Ecuador 2
GT - Guatemala 2
MA - Marocco 2
MX - Messico 2
NZ - Nuova Zelanda 2
PA - Panama 2
PY - Paraguay 2
SC - Seychelles 2
TH - Thailandia 2
UY - Uruguay 2
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IQ - Iraq 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 9.900
Città #
Ann Arbor 1.897
Singapore 499
Wilmington 346
Chandler 323
Frankfurt am Main 266
Dublin 261
Dearborn 236
Milan 215
Hong Kong 191
Ashburn 189
Woodbridge 185
Houston 145
New York 145
Fairfield 139
Princeton 134
Santa Clara 124
Nanjing 112
Jacksonville 86
Boardman 76
Moscow 65
Seattle 65
Guangzhou 56
Jakarta 46
Shanghai 43
Nanchang 42
Dong Ket 41
Cambridge 37
Los Angeles 34
Lawrence 32
Beijing 31
Shenyang 29
Vienna 29
Altamura 26
Hangzhou 23
Shangdi 21
Toronto 21
Jinan 20
Pune 20
Ottawa 19
Zhengzhou 19
Brussels 17
Council Bluffs 17
Kunming 17
Sacramento 16
Andover 15
Fremont 15
Sydney 15
Falls Church 14
Kocaeli 14
Mainz 14
Portland 14
Chicago 12
Edmonton 12
San Diego 12
Tianjin 12
Changsha 11
Helsinki 11
Lissone 11
Dallas 10
London 10
Norwalk 10
Nuremberg 10
Hebei 9
Jiaxing 9
Lachine 9
Rome 9
Turku 9
Coventry 8
Düsseldorf 8
Hefei 8
Kiev 8
Yuseong-gu 8
Canazei 7
Grafing 7
Phoenix 7
Boston 6
Brooklyn 6
Cagliari 6
Chengdu 6
Codroipo 6
Frederick 6
Montreal 6
Munich 6
Paris 6
Philadelphia 6
Belo Horizonte 5
Induno Olona 5
Kolkata 5
Merate 5
Ningbo 5
Pavia 5
Taizhou 5
Takasago 5
Wroclaw 5
Zagreb 5
Brno 4
Cairo 4
Carate Brianza 4
Chennai 4
Cislago 4
Totale 6.813
Nome #
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 316
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 316
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 284
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 257
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 244
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 238
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 238
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 238
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 235
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 227
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 223
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 216
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 212
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 211
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 210
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 200
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 200
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 196
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 190
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 185
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 171
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 169
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 168
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 162
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 159
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 153
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 150
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 149
Multimodal experimental approach to the study of human neurological diseases 147
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 147
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 146
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 146
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 145
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 145
Genetic factors influencing the development of vincristine-induced neurotoxicity 145
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 142
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 141
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 140
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 139
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 139
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 138
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 138
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 135
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 134
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 130
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 127
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 126
Pharmacokinetics of IVIg in Wistar rats 122
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 121
In vitro neurotoxicity of new promising metal-based anticancer complexes 112
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 109
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 109
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 108
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 107
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 107
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 106
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 105
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 102
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 102
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 101
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 95
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 84
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 78
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 77
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 73
Blood NfL as a potential axonal damage marker in different CIPN rat models. 73
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 67
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 57
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 57
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 50
Totale 10.689
Categoria #
all - tutte 37.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 0 20
2020/20212.104 44 49 215 185 149 216 253 252 189 148 163 241
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20252.383 139 363 248 115 236 92 189 97 286 396 222 0
Totale 10.689